Koehler J, Stengel A, Hofmann T, et al. - Because depression represents a frequent comorbidity in chronic heart failure (CHF) patients, therefore, researchers explored the impact of telemonitoring on depressive symptoms during 12 months, by performing this pre‐specified subgroup analysis of the Telemedical Interventional Monitoring in Heart Failure (TIM‐HF) trial. A total of 710 patients with CHF were randomized, in the TIM‐HF study, to either usual care (UC) or a telemedical intervention (TM) using non‐invasive devices for daily monitoring electrocardiogram, blood pressure and body weight. Using the 9‐item Patient Health Questionnaire (PHQ‐9), depression was assessed. Improved PHQ‐9 scores were noted in patients randomized to telemedicine whereas UC patients remained constant. The TM group had improved quality of life parameters, relative to UC. Overall, telemedical care not only conferred an improvement in depressive symptoms but also positively impacted the quality of life in patients with CHF and moderate depression.